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ABSTRACT 
 
Pregnant women are highly vulnerable to malaria infection in its endemic areas, particularly 
infection by Plasmodium falciparum that can cause premature, low birth weight, severe anemia in 
pregnant women, and death. Sulfadoxine-pyrimethamine (SP) for Intermittent Preventive Treatment 
for pregnant (IPTp) is used for malaria control in pregnancy recommended by the World Health 
Organization that has already been implemented in Africa. The P. falciparum resistance to SP has been 
reported in several malarial endemic areas, and mutations in the genes of Plasmodium falciparum 
Dihydrofolate Reductase (Pfdhfr) and Dihydropteroate Synthase (Pfdhps) are shown to be associated 
with parasite resistance to SP treatment. Genetic analysis of Pfdhfr and Pfdhps genes in pregnant women 
infected with P. falciparum has not yet been examined in Indonesia.  The cross-sectional study was 
conducted at two subdistricts, Sungai Pinang and Peramasan, in Banjar district of South Kalimantan 
Province, where 127 pregnant women were recruited from 2008 to April 2010. Two important 
mutations in Pfdhfr gene (amino acid positions at N51 and S108) and three in Pfdhps gene (A437, K540 
and A581) were analyzed by nested PCR-RFLP method. All of the seven pregnant women samples 
infected with P. falciparum presented PfDHFR 108N and PfDHPS 437G mutations. One of the samples 
had the additional mutation at PfDHPS 540, in which Lys is substituted by Glu. These results 
suggested that P. falciparum might present only some resistance to SP at Sungai Pinang and Peramasan 
subdistricts, Banjar District, South Kalimantan province, Indonesia. Although there were limited 
number of samples, this study showed only few mutations of Pfdhfr and Pfdhps genes in P. falciparum at 
Banjar district, South Kalimantan Province, that suggests SP might be effective for IPTp in this area. 
Thus, further analysis of the other mutation sites in Pfdhfr and Pfdhps genes and in vivo efficacy study 
of SP with more sufficient sample numbers will be necessary to confirm this preliminarily result . 
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BACKGROUND 
Pregnant women in malaria endemic areas are 
highly vulnerable to malaria infection, 
particularly Plasmodium falciparum (P. falciparum) 
infection that can cause prematurity, low birth 
weight (LBW), severe anemia and death. 
Complications are more common  in  the  Primi- 
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gravidae than multigravidae [1-3]. As a 
consequence   of    the   impact   of   malaria   on 
pregnancy, malaria control during pregnancy 
requires the highest attention and carefulness. 
World Health Organization (WHO) has 
recommended the use of sulphadoxine-
pyrimethamine (SP) for intermittent preventive 
treatment (IPT) for malaria control in pregnancy. 
This policy has been implemented in Africa [4]. 
SP has been proven safe for the second and third 
trimester of pregnancy. It has an affordable 
price, is widely available, needs a single dose 
treatment and is effective in reducing the risk of 
LBW and placental malaria [5-7]. 
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However, the level of resistance to SP has 
increased and rapidly spread due to the parasite’s 
ability to perform gene mutation as a response to 
drug pressure, that is, the occurrence of point 
mutations in genes that are targeted by the drug 
[8]. Monitoring molecular markers of SP 
resistance is very valuable to determine drug 
policy for the prevention and treatment of 
malaria in pregnancy [9]. Mutations in PfDHFR 
and  PfDHPS genes are associated with 
resistance of P. falciparum to SP. Key mutations 
of resistance to pyrimethamine is PfDHFR gene 
mutation at codon 108 which has been a change 
SerAsn or SerThr, and point mutations in 
three other codons of 51 [AsnIle], 59 
[CysArg], and 164 [IleLeu]. Mutations in 
PfDHPS associated with resistance to 
sulfadoxine is SerAla or SerPhe at codon 
436, AlaGly at codon 437, LysGlu at codon 
540, AlaGly at codon 581, AlaThr or 
AlaSer at codon 613[10-19]. The presence of 
mutations at codons 437 and 540 of PfDHPS 
together with the triple mutation of PfDHFR 
[quintuple mutation] is a significant predictor of 
SP treatment failure [20].  
In Indonesia, SP had been used as an 
alternative malaria drug since 1999 [21] and was 
still used in Banjar district until 2009 [22]. The 
first cases of SP resistance in Indonesia were 
encountered in 1979 [23], followed by their 
occurences in several provinces of Indonesia [24-
26]. Research on the effectiveness of SP in 
association with mutations of genes coding for 
PfDHFR and PfDHPS in several malarial 
endemic areas and also in pregnant women in 
several malarial endemic areas in Africa have 
been conducted [24-29]. Therefore, World 
Health Organization released the 
recommendation of a threshold of a parasite 
genetic marker of SP-resistance (50% prevalence 
of the pfdhps 540) above which SP-IPTp is not 
recommended for use in Africa [30]. However, 
no information is available in particular for 
pregnant women infected with P. falciparum in 
malaria endemic areas in Indonesia. This study 
aims to determine the mutations of Pfdhfr and 
Pfdhps genes in pregnant women infected with 
P. falciparum at Peramasan and Sei Pinang 
subdistricts, Banjar District, South Kalimantan 
Province, that belong to malaria endemic areas. 
 
MATERIALS AND METHODS 
Study sites   
The study was carried out at two subdistricts, 
Sungai Pinang and Peramasan, in Banjar district, 
South Kalimantan Province. The topography of 
Peramasan subdistrict is mountainous and 
surrounded by dense forests and shrubs, with 
small rivers in between meetings of the mountain 
[see Figure 1]. The population was 3,730 
inhabitants in which most people work as 
farmers and traditional gold miners. Sungai 
Pinang is an area of rolling hills scattered in 
mountainous areas Meratus in which some 
villages belong to remote areas. The population 
was 16,245 inhabitants in 2008 in which most of 
people work as farmers. The most common 
vectors are Anopheles balabacensis, Anopheles 
maculatus, Anopheles letifer, Anopheles umbrosus, 
Anopheles kochi, Anopheles nigerrimus, and Anopheles 
vanu [22]. 
 
Figure 1. Sampling positions at Sungai Pinang (green) and 
Peramasan sub districts (blue). 1. Kupang Rejo 
village; 2. Sungai Pinang; 3. Pakutik; 4. Rantau 
Nangka;  5. Rantau Bakula; 6. 
Belimbing Baru; 7. Peramasan Atas;  8. 
Peramasan Bawah;  9.   Remo; 10. Angkipih; 11. 
Belimbing Lama; 12. Sumber Baru; 13. Sumber 
Harapan; 14. Kahela’an; 15. Hakim Makmur 
 
Participants  
The cross-sectional study was conducted. 
Pregnant women presenting for routine antenatal 
care at Sungai Pinang and Peramasan Health 
Centres were recruited from 2008 to April 2010. 
The study protocol was reviewed and approved 
by the Ethics Committee of Medical Research, 
Faculty of Medicine, Airlangga University, 
Surabaya, No. 26 /EC / KEPK /FKUA  /2010. 
Informed consent was obtained from all 
participants.  
 
Species Identification 
Malaria screening used Giemsa stained thin 
and thick blood smears under microscopy by 
local staffs. Blood samples for the molecular 
analysis were collected on filter paper (Advantec, 
Toyo Roshi Kaisha, Ltd., Japan). Malaria parasite 
densities were counted per 200 white blood cells 
(WBC) on Giemsa stained thin and thick smears, 
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calculated as parasites per microliter. 
Submicroscopic plasmodial infections and 
parasite species were assessed by nested 
polymerase chain reaction (PCR) assays after 
extraction of DNA from filter paper (QIAmp 
Blood Kit, Qiagen, Hilden, Germany). 
 
 Detection of the PfDHFR and PfDHPS 
mutations.  
We analyzed two point mutations in the Pfdhfr 
gene (51 and 108) and three point mutations in 
the Pfdhps gene (437, 540 and 581). The detection 
of mutations in Pfdhfr and Pfdhps was carried out 
by using nested PCR followed by restriction 
fragment length polymorphism (RFLP)[31-32]. 
The first-round PCR amplification was 
performed in a 20 l mixture containing 2 l of 
DNA sample, 200 M dNTP, 0.4 M of each 
primer, as described by previouse report [33], 
and 1 U Taq polymerase (Takara Ltd, Japan). 
Nested PCR was performed in a 15 l mixture 
containing 2 l of the first PCR product with 
10X dilution. RFLP was performed by 
administering the enzyme digestion at optimum 
temperature and time required as in the brochure 
from the manufacturer. Five microliters of 
nested PCR products were used without 
purification in the total volume of 50 l 
containing 5 U/ l enzyme digestion, 5 l buffer, 
5 l BSA and 30 l distilled water. The digestion 
products were detected by ethidium bromide 
stained 2% agarose gel under UV light after 
electrophoresis. For the Pfdhfr mutations, AluI 
cut only the wild-type gene (S108), BsrI cut only 
the mutant gene (108N) and ScrFI cut only the 
mutant gene (108T).  Tsp509I only cut the wild-
type gene (51I). For the Pfdhps mutations, AvaII 
cut only the mutant gene (437G), FokI cut only 
the mutant gene (540E) and BstUI cut only the 
mutant gene (581G). For each series of samples, 
water was used as a negative control. For the 
detection of 108N, 3D7-DNA was used as the 
wild-type control, K1-DNA was used as the 
mutant control of 108N, and FCR3-DNA was 
used as the mutant control of 108T. For the 
detection of 437G, FCR3-DNA was used as the 
wild-type control, while 3D7 and K1-DNA were 
used as the mutant control of 437G.  
 
RESULT AND DISCUSSION 
Subject Characteristics 
Total 127 pregnant women were involved in 
this study, consisting of 30 pregnant women 
from Peramasan Health Centre and 97 pregnant 
women from Sungai Pinang Health Centre (HC). 
Most of the pregnant women aged between 20-
30 years, 60% in Peramasan HC and 54% in Sei 
Pinang HC. They represented mostly at the first 
pregnancy (primigravida) compared with at the 
second pregnancy and the third or more 
pregnancy, 13 [43%] in Peramasan HC and 48 
[49%] in Sei Pinang HC.   
 
Species Identification 
In Peramasan HC, malaria screening resulted 
in 10 pregnant women infected with Plasmodium, 
while 13 pregnant women were infected with 
Plasmodium in Sungai Pinang HC. The species 
identification by nested PCR resulted in 12 
malaria cases among these pregnant women, 6 
pregnant women with malaria occurred in each 
health centre. The identification of malaria 
parasites infected to pregnant women was shown 
in Table 1. The pregnant women with malaria 
were manifested in the fever that appeared as a 
dominant malarial symptom. 
 
Mutations of PfDHFR and PfDHPS 
Genes 
Six of seven samples pregnant women with 
malaria falciparum had the double mutation 
which consisted of PfDHFR 108N mutation and 
the single mutation of PfDHPS gene 437G. One 
sample had the triple mutations which consisted 
of 108N mutation in pfdhfr gene and the double 
mutation of PfDHPS (437G and 540E). The 51I 
and 108T mutations in the Pfdhfr gene and the 
581G mutation in the Pfdhps gene were not 
observed in this study (see table 2). 
We found two types of PfDHFR, PfDHPS 
mutants in seven P falciparum isolates in Banjar 
district, particularly in Sei Pinang and Peramasan 
subdistricts.  All isolates, except one, contained 
the PfDHFR 108N/PfDHPS 437G double 
mutant. One isolation contained the PfDHFR 
108N/PfDHPS 437G/540E triple mutant. 
Recently, PfDHPS 540E mutant has been 
demonstrated as a predictor for P. falciparum 
resistance to SP. When PfDHPS 540E mutant 
was joined together with the triple mutation of 
PfDHFR as the quintuple mutation, it indicates a 
significant predictor of SP treatment failure. 
Below 50% prevalence of the PfDHFR 540 
mutation is used as a threshold of a parasite 
genetic marker of SP-resistance, in the program 
of Intermittent Preventive Treatment (IPT) 
during infancy in Africa [20, 30, 34, 35]. One 
isolate containing PfDHPS 540E mutant found 
in our study with the mutation of PfDHFR 108N 
and mutation of PfDHPS 437G as the triple 
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mutations. The other six isolates presented the 
wild type K540 PfDHPS, and it suggested 
parasites might be quite sensitive to SP 
treatment. However, further studies with 
sufficient numbers of samples are required for 
finding out the appropriate prevalence of 
PfDHPS 540E mutant in order to provide the 
recommendation for SP-IPTp implementation in 
Indonesia. Moreover, one needs to clarify the 
other point mutations in association to SP 
resistance by in vivo study for efficacy of SP 
combined with the analysis of molecular marker 
of SP resistance. 
 
 
Table 1. The determintaion of malaria parasites in pregnant women with malaria  
Health Centre   Microscopy*    Nested PCR 
   Pf Pv Mix Pf and Pv  Pf Pv Mix Pf and Pv 
 
Sungai Pinang  1 5  4  1 3  2 
Peramasan  3 6  4  3 2  1 
 
* Malaria screening used Giemsa stained thin and thick blood smear under microscopy.  
Pf: P. falciparum, Pv: P.  Vivax; Mix Pf and Pv: mixed infection of Pf and Pv 
 
 
Table 2.  PfDHFR and PfDHPS gene mutations, and density of parasites /ul blood sample in pregnant women infected 
with P. falciparum in Sungai Pinang and Peramasan Health Centers  
 
Sample 
Microscopy Nested PCR-RFLP 
 PfDHFR PfDHPS 
Pf Mix Pf and Pv density of parasites / ul 51 108 437 540 581 
KH1 Pf  35405 asn asn gly lys ala 
KH6*  mix  33742 asn asn gly lys ala 
KH9  mix  320 asn asn gly glu ala 
KH14* Pf  45962 asn asn gly lys ala 
KH16*  mix  4815 asn asn gly lys ala 
KH17 Pf  2395 asn asn gly lys ala 
KH23 Pf  6834 asn asn gly lys ala 
Mix Pf and Pv: mixed infections of Pf and Pv;  Mutated codon is marked with bold letters;  * Samples from the Sungai 
Pinang health center  
 
There were two types of isolates containing 
PfDHFR and PfDHPS mutants in Peramasan 
subdistrict. In fact, the people’s mobilization was 
high in here due to the development of social 
and economy, i.e. mining in the forest, 
plantations and agricultural industries. The 
workers in mining and forestry are seasonal and 
come not only from South Kalimantan but also 
from various regions in Indonesia, including Java 
and Papua that belong to malaria endemic areas 
[22, 36]. So, there is a great chance for the spread 
of PfDHFR and PfDHPS mutants from other 
malaria endemic areas such as Java or Papua. 
Whereas in Sungai Pinang subdistrict, there was 
one type of isolations containing PfDHFR and 
PfDHPS mutants (PfDHFR 108N/PfDHPS 
437G). The people’s mobilization in here was 
low. However, the limited isolations found in 
Sungai Pinang were not easy to illustrate this 
matter. 
Based on the previous studies in Indonesia 
and its neighboring countries, the pattern of 
mutations of PfDHFR and PfDHPS genes in 
isolations was various. For instance, in 
Purworejo, Central Java, there was found a single 
mutation of PfDHFR gene 108N/108T or paired 
with 59R/164L and a single mutation of  
PfDHPS gene 437G or paired with the 540E. In 
Sumba and Timor Leste, there was obtained the 
108N and 51I double mutations in Pfdhfr gene 
and a single 437G mutation in Pfdhps gene [36-
39]. In Papua New Guinea, there was found the 
gene mutation 108N and 59R and single 
mutation PfDHPS  437G or paired with the 
540E [38, 41].  Our study analyzed only two 
codons of 51 and 108 in Pfdhfr gene and 
detected mutation at 108 only, while 5. the other 
possible mutation at 59 has been reported in 
Indonesia and Southeast Asia [42]. So, it is 
possible that the mutations of PfDHFR gene in 
pregnant women with falciparum malaria who 
live in Sungai Pinang and Peramasan may not 
only carry the one mutation but also may carry 
the other mutations, including the mutation in 
codon of 59 and of 164.  This codon needs to be 
analyzed in further study, whereabout the 
presence of triple mutations of PfDHFR 
together with two mutations of PfDHPS (437G 
and 540E) could be the predictor for SP 
resistance [20, 30].  
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Pregnant women with malaria having no 
willing to participate and no visiting HC due to 
their homes in remote areas might cause the 
limited isolations in our study. On the other 
hands, the prevalence of malaria in pregnant 
women was 35.7% in three months under active 
detection by Riyanto [36], 12.8% under passive 
detection at the two health centers in the study 
sites, and most people living in these areas 
(83.3%) used bed-nets in 2008 under research 
observation by WHO (unpublished). There is a  
good road now with a public transportation from 
HC to a district hospital, which creates an ease 
for for people movements. These environmental 
situation change might have influenced to our 
study of limited number of sample isolations. 
Even though limited number of malaria 
infected pregnant women could be recruited and 
some of the important mutation sites were 
analyzed in this preliminary study yet, we could 
provide a basic important information and 
necessity of further malaria drug resistance 
information to guide drug policy on the 
prevention and treatment of malaria in 
pregnancy. 
 
CONCLUSION 
Although there was limited number of 
samples, this study shows only a few mutations 
of PfDHFR and PfDHPS gene in P. falciparum at 
Banjar district, South Kalimantan Province, that 
suggests SP might be effective for IPTp 
resistance to SP at this area. Thus, further 
analysis of the other mutation sites in Pfdhfr and 
Pfdhps genes and in vivo efficacy study of SP 
with more sufficient sample numbers will be 
necessary to confirm this preliminarily result. 
Therefore, further research is needed with a lot 
of isolations for the sake of 1] clarifying more 
the point of mutation in relation to SP resistance 
by in vivo study for efficacy of SP combined 
with analysis of molecular marker of SP 
resistance, 2] finding out the appropriate 
prevalence of PfDHPS 540 mutant, and 3] 
finding out the predictive value of the PfDHFR 
and PfDHPS mutations for IPT with SP. 
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